N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan

Sydney Childrens Hospital KCC, Randwick

AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta

C.S Mott Children's Hospital, Ann Arbor

University of Chicago Comer Children's Hospital, Chicago

Cook Children's Medical Center - Fort Worth, Fort Worth

Children Hospital of Colorado, Aurora

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

Children's Hospital and Regional Medical Center - Seattle, Seattle

Children's Hospital Los Angeles, Los Angeles

Childrens Hospital Boston, Dana-Farber Cancer Institute., Boston

Cincinnati Children's Hospital Medical Center, Cincinnati

Children's Hospital of Philadelphia, Philadelphia

Hospital for Sick Children, Toronto